Health & Wellness Today New York
SEE OTHER BRANDS

Get your fresh news on health and wellness in New York

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health & Wellness Today New York.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Quipt Home Medical Corp. - QIPT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Quipt Home Medical Corp. - QIPT

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT). Such investors are advised to contact Danielle Peyton at...

UNITEDHEALTH CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against UnitedHealth Group Incorporated and Encourages Investors to Contact the Firm

UNITEDHEALTH CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against UnitedHealth Group Incorporated and Encourages Investors to Contact the Firm

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the...

AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Amylyx (AMLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Amylyx Pharmaceuticals, Inc....

Ola Digital Health Partners with Elite Care Provider Network to Expand Telehealth Access Across All 50 States

Ola Digital Health Partners with Elite Care Provider Network to Expand Telehealth Access Across All 50 States

In a pivotal advancement for nationwide digital healthcare delivery, Ola Digital Health today announced its partnership with Elite Care Provider Network (ECPN) NEW YORK, NY, UNITED STATES, July 11, 2025 /⁨EINPresswire.com⁩/ -- New York, NY — [10th...

ROSEN, A TOP-RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

ROSEN, A TOP-RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive...

Gramercy Physical Therapy Expands One-on-One Manual Therapy and Custom Orthotics Services in NYC

Gramercy Physical Therapy Expands One-on-One Manual Therapy and Custom Orthotics Services in NYC

Gramercy PT enhances personalized rehab in NYC with expanded manual therapy, custom orthotics, and AFO fittings for patients with neurological gait issues. NEW YORK, NY, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- Gramercy Physical...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Petco Health and Wellness Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WOOF

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Petco Health and Wellness Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WOOF

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates...

Attorney General James Sues to Block Trump Administration’s Unlawful Attacks on Gender-Affirming Care

Attorney General James Sues to Block Trump Administration’s Unlawful Attacks on Gender-Affirming Care

NEW YORK – New York Attorney General Letitia James today led a coalition of 15 other states and the District of Columbia in suing the Trump administration for attacking access to gender-affirming health care for transgender and nonbinary youth....

HIMS FRAUD ALERT: Hims & Hers Health, Inc. 34% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by August 25 (NYSE:HIMS)

HIMS FRAUD ALERT: Hims & Hers Health, Inc. 34% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by August 25 (NYSE:HIMS)

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company’s senior executives for potential...

Fat Traps and Fatbergs: The History and Consequences for NYC’s Sewers

Fat Traps and Fatbergs: The History and Consequences for NYC’s Sewers

Grease traps – sometimes called fat traps – are simple plumbing devices designed to intercept fats, oils and grease (FOG) before they enter a sewer line. BROOKLYN, NY, UNITED STATES, July 13, 2025 /⁨EINPresswire.com⁩/ -- Grease traps – sometimes...

From Tech-Driven Health to Herbal Healing: What’s New in Wellness This Season

From Tech-Driven Health to Herbal Healing: What’s New in Wellness This Season

NEW YORK, NY, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- With more travelers planning trips around overall wellbeing and natural healing new spa openings are focusing less on pampering and more on restoring the body through nature,...

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase 3 TRANSCEND study underscore potential efficacy of setmelanotide, including with prior use or concomitant use...

Shareholders that lost money on Petco Health and Wellness Company, Inc. (WOOF) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Shareholders that lost money on Petco Health and Wellness Company, Inc. (WOOF) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to...

Outsourcing Bookkeeping Services Helps Healthcare Providers Streamline Finances and Ensure Compliance

Outsourcing Bookkeeping Services Helps Healthcare Providers Streamline Finances and Ensure Compliance

Streamline healthcare finance with IBN Technologies outsourcing bookkeeping services. MIAMI, FL, UNITED STATES, July 11, 2025 /⁨EINPresswire.com⁩/ -- Healthcare providers across the United States are increasingly focused on improving operational...

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks...

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the...

ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV

ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the...

Lowey Dannenberg Notifies UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDQ: URGN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Lowey Dannenberg Notifies UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDQ: URGN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against UroGen Pharma Ltd. (“UroGen” or the “Company”)...

Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Interleukin-2 (IL-2) inhibitors are immunosuppressive...

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions